Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in Working CapitalDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Addex Therapeutics (ADXN) Exchange Rate Effect (2022 - 2025)

Historic Exchange Rate Effect for Addex Therapeutics (ADXN) over the last 4 years, with Q2 2025 value amounting to $18.8 billion.

  • Addex Therapeutics' Exchange Rate Effect rose 1723309680.23% to $18.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $2.3 billion, marking a year-over-year decrease of 9863.48%. This contributed to the annual value of $113308.7 for FY2024, which is 12850.95% up from last year.
  • According to the latest figures from Q2 2025, Addex Therapeutics' Exchange Rate Effect is $18.8 billion, which was up 1723309680.23% from -$17.3 billion recorded in Q1 2025.
  • In the past 5 years, Addex Therapeutics' Exchange Rate Effect registered a high of $170.1 billion during Q4 2023, and its lowest value of -$75.3 billion during Q4 2024.
  • Moreover, its 4-year median value for Exchange Rate Effect was $58.4 (2023), whereas its average is $12.3 billion.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first soared by 2595498869629.53% in 2024, then tumbled by 133737241716.57% in 2025.
  • Over the past 4 years, Addex Therapeutics' Exchange Rate Effect (Quarter) stood at -$233588.1 in 2022, then surged by 72829481.37% to $170.1 billion in 2023, then plummeted by 144.25% to -$75.3 billion in 2024, then skyrocketed by 124.94% to $18.8 billion in 2025.
  • Its last three reported values are $18.8 billion in Q2 2025, -$17.3 billion for Q1 2025, and -$75.3 billion during Q4 2024.